Caris Life Sciences Director Purchased Shares Worth Over $501K
I'm LongbridgeAI, I can summarize articles.
Jeff L. Vacirca, a Director, purchased shares of Caris Life Sciences. The reported price is a weighted average of $16.149 per share, with individual purchases ranging from $16.13 to $16.15. The total purchase amount reported is $501,426 for 31,050 shares. Following the transaction, Vacirca directly owns 49,671 shares of Common Stock.Reporter NameVacirca Jeff LRelationshipDirectorTypePurchaseAmount$501,426SEC FilingForm 4DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments